Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0242706 (
hyperoxia
)
5,219
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The physiological response of two central nervous system neurotransmitter receptors to oxidative stress was studied using the rat model of
hyperoxia
. We show that
hyperoxia
leads to a decline in the ability of isoproterenol (ISO) to augment GABAergic responses in cerebellar Purkinje neurons in vivo. This effect is reversed by the N-tert-butylalpha-phenylnitrone (PBN). We also show that
hyperoxia
produces a decline in the ability of oxotremorine (OXO) to stimulate dopamine (DA) release in striatal slices. This effect is accompanied by an increase in hydroxyl radical levels in the CNS reflected in an increase in 2,3-
DHBA
, suggesting that the change is the result of an increased level of oxidative stress. We also show a time dependent effect of
hyperoxia
on both beta-adrenergic and muscarinic receptor function. We examined the interaction between age and
hyperoxia
exposure and found that in 12-month-old rats there is a decline in the baseline response prior to oxygen exposure that may interfere with observing a subsequent effect of
hyperoxia
. Differential effects were observed between the cerebellum and striatum with respect to the interaction of age and time of oxygen exposure. Overall, the data suggest that age and
hyperoxia
may be acting via a common mechanism because there was no synergistic effect of the two conditions.
...
PMID:Effect of normobaric hyperoxia on two indexes of synaptic function in Fisher 344 rats. 1023 24
Inhaled nitric oxide (iNO) is used as a selective pulmonary vasodilator, and often under conditions when a high fraction of inspired oxygen is indicated. However, little is known about the potential toxicity of iNO therapy with or without concomitant oxygen therapy. NO can combine with superoxide (O2-) to form peroxynitrite (ONOO-), which can in turn decompose to form hydroxyl radical (OH.). Both OH. and ONOO- are involved in various forms of lung injury. To begin evaluation of the effect of iNO under either normoxic or hyperoxic conditions on OH. and/or ONOO- formation, rats were exposed for 58 h to either 21% O2, 21% O2 + 10 parts per million (ppm) NO, 21% O2 + 100 ppm NO, 50% O2, 90% O2, 90% O2 + 10 ppm NO, or 90% O2 + 100 ppm NO. We used a salicylate hydroxylation assay to detect the effects of these exposures on lung OH. and/or ONOO- formation measured as the appearance of 2,3-dihydroxybenzoic acid (2,3-
DHBA
). Exposure to 90% O2 and 90% O2 + 100 ppm NO resulted in significantly (p < 0.05) greater lung wet weight (1.99 +/- 0.14 g and 3.14 +/- 0.30 g, respectively) compared with 21% O2 (1.23 +/- 0.01 g). Exposure to 21% O2 + 100 ppm NO led to 2.5 times the control (21% O2 alone) 2,3
DHBA
formation (p < 0.05) and exposure to 90% O2 led to 2.4 times the control 2,3-
DHBA
formation (p < 0.05). However, with exposure to both 90% O2 and 100 ppm NO, the 2,3-
DHBA
formation was no greater than the control condition (21% O2). Thus, these results indicate that, individually, both the
hyperoxia
and the 100 ppm NO led to greater salicylate hydroxylation, but that the combination of
hyperoxia
and 100 ppm NO led to less salicylate hydroxylation than either did individually. The production of OH. and/or ONOO- in the lung during iNO therapy may depend on the ratio of NO to O2.
...
PMID:The effect of inhaled nitric oxide and oxygen on the hydroxylation of salicylate in rat lungs. 1278 87